The STAT3/STAT5 signaling dysregulates a plethora of cellular processes in EOC, which results in uncontrolled cancer cell proliferation, induction of angiogenesis, promotion of metastasis factors, and suppression of host immune response. The gene discussed is STAT5B; the disease is cancer.